Skip to content
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price of prescription drugs with markups that can exceed 1,000%, according to […]
FTC’s second report on PBMs blasts drug price markups of 1,000% Read More »
As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan.
BIO CEO urges innovation in access at White House CGT forum Read More »
The Centers for Medicare & Medicaid Services (CMS) issued a directive telling private insurers providing Medicare Advantage (MA) plans to cover Biogen’s amyotrophic lateral sclerosis
CMS directs insurers to cover ALS drug Qalsody Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
The U.S. Department of Agriculture (USDA) on Nov. 12 announced that biotech plants made through modifications that could have been achieved by conventional breeding can be
APHIS exempts more types of biotech plants from regulation Read More »
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »
As the world gathers in Baku, Azerbaijan, for the COP29 United Nations Climate Summit, the Biotechnology Innovation Organization (BIO) is ensuring biotech’s role in
BIO to present biotech’s benefits for climate and food at COP29 Read More »
Biotech apples designed to last longer, taste great, and make superior cider were the stars when Rep. Dan Newhouse (R-WA) toured Okanagan Specialty Fruits’
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply Read More »
